Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A-375 | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 2 | 1440 | 149 | 0.0702 | 0.0695 | 0.1035 | 0.1086 |
A-375 | Vemurafenib | PF562271 | 0.000 | 3.160 | uM | 72 | hr | 1 | 1622 | 180 | 0.0784 | 0.0695 | 0.1110 | 0.1086 |
A-375 | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 3 | 8504 | 397 | 0.4410 | 0.4696 | 0.0467 | 0.0532 |
A-375 | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 2 | 9759 | 545 | 0.5012 | 0.4696 | 0.0558 | 0.0532 |
A-375 | Vemurafenib | PF562271 | 0.000 | 1.000 | uM | 72 | hr | 1 | 9095 | 519 | 0.4665 | 0.4696 | 0.0571 | 0.0532 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 3 | 18188 | 934 | 0.9386 | 0.8926 | 0.0514 | 0.0523 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 2 | 18224 | 910 | 0.9418 | 0.8926 | 0.0499 | 0.0523 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.316 | uM | 72 | hr | 1 | 15518 | 861 | 0.7973 | 0.8926 | 0.0555 | 0.0523 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 3 | 18973 | 930 | 0.9815 | 1.0000 | 0.0490 | 0.0485 |
A-375 | Vemurafenib | PF562271 | 0.000 | 0.000 | uM | 72 | hr | 2 | 19375 | 946 | 1.0025 | 1.0000 | 0.0488 | 0.0485 |